SCHEMBL3866264

SCHEMBL3866264

O=[N+]([O-])c1ccc(NC(CO)CO)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.57
CA1 P00915 1/20 0.57
MMP2 P08253 1/20 0.57
MMP9 P14780 1/20 0.57
MMP8 P22894 1/20 0.57
MMP14 P50281 1/20 0.57
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
LMNA P02545 3/20 0.51
ALDH1A1 P00352 5/20 0.50
MAPT P10636 3/20 0.50
RECQL P46063 1/20 0.50
HSD17B10 Q99714 1/20 0.50
HTT P42858 3/20 0.49
TSHR P16473 1/20 0.47
HPGD P15428 1/20 0.47
ALOX12 P18054 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
GLA P06280 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6671268 0.90 MAPT (0.53) CA12CA1MMP2MMP9MMP8
SCHEMBL6570551 0.90 MAPT (0.53) CA12CA1MMP2MMP9MMP8
SCHEMBL5127357 0.87 ALDH1A1 (0.53) CA12CA1MMP2MMP9MMP8
SCHEMBL5119014 0.87 MAPT (0.50) CA12CA1MMP2MMP9MMP8
SCHEMBL5119021 0.87 MAPT (0.50) CA12CA1MMP2MMP9MMP8
SCHEMBL5127362 0.87 ALDH1A1 (0.53) CA12CA1MMP2MMP9MMP8
SCHEMBL6003995 0.82 MAPT (0.45) CA12CA1MMP2MMP9MMP8
SCHEMBL9362332 0.82 MAPT (0.45) CA12CA1MMP2MMP9MMP8
SCHEMBL5155046 0.82 ALDH1A1 (0.52) CA12CA1MMP2MMP9MMP8
SCHEMBL6824926 0.82 CA12 (0.54) CA12CA1MMP2MMP9MMP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119709797-A Broad-spectrum amidase gene aphA for degrading amidol antibiotics and amidic herbicides, and encoding protein and application thereof 南京农业大学 2025-03-28 CN disclosed
EP-1948594-B1 PROCESS FOR THE SYNTHESIS OF INTERMEDIATES OF CHLORAMPHENICOL OR ITS ANALOGUES KRKA (SI) 2013-02-27 EP disclosed
US-7591860-B2 N-alkylpolyhydroxylated secondary para-phenylenediamines, dye compositions comprising them, processes, and uses thereof L'OREAL, S.A. (FR) 2009-09-22 US disclosed
US-7591860-B2 N-alkylpolyhydroxylated secondary para-phenylenediamines, dye compositions comprising them, processes, and uses thereof L'OREAL, S.A. (FR) 2009-09-22 US disclosed
US-7591860-B2 N-alkylpolyhydroxylated secondary para-phenylenediamines, dye compositions comprising them, processes, and uses thereof L'OREAL, S.A. (FR) 2009-09-22 US disclosed
US-20090149657-A1 PROCESS FOR THE SYNTHESIS OF INTERMEDIATES OF CHLORAMPHENICOL OR ITS ANALOGUES KRKA (SI) 2009-06-11 US disclosed
EP-1948594-A1 PROCESS FOR THE SYNTHESIS OF INTERMEDIATES OF CHLORAMPHENICOL OR ITS ANALOGUES KRKA (SI) 2008-07-30 EP disclosed
WO-2007054147-A1 PROCESS FOR THE SYNTHESIS OF INTERMEDIATES OF CHLORAMPHENICOL OR ITS ANALOGUES KRKA (SI) 2007-05-18 WO disclosed
EP-1785414-A1 Process for the synthesis of intermediates of chloramphenicol or its analogues KRKA, tovarna zdravil, d.d., Novo mesto (SI) 2007-05-16 EP disclosed
US-20060026777-A1 N-alkylpolyhydroxylated secondary para-phenylenediamines, dye compositions comprising them, processes, and uses thereof L'OREAL S.A. (FR) 2006-02-09 US disclosed
EP-1580184-A1 secondary N-alkylepolyhydroxilated p-phenylendiamines, dye composition comprising them, processes and uses L'OREAL (FR) 2005-09-28 EP disclosed
US-20020072062-A1 Chloramphenicol biosynthetic pathway and gene cluster DIVERSA CORPORATION 2002-06-13 US disclosed
EP-1203083-A1 CHLORAMPHENICOL BIOSYNTHETIC PATHWAY AND GENE CLUSTER CHARACTERIZATION Diversa Corporation (US) 2002-05-08 EP disclosed
WO-2000070056-A9 CHLORAMPHENICOL BIOSYNTHETIC PATHWAY AND GENE CLUSTER CHARACTERIZATION DIVERSA CORP (US) 2001-11-29 WO disclosed
WO-2000070056-A1 CHLORAMPHENICOL BIOSYNTHETIC PATHWAY AND GENE CLUSTER CHARACTERIZATION DIVERSA CORPORATION (US) 2000-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060026777-A1 N-alkylpolyhydroxylated secondary para-phenylenediamines, dye compositions comprising them, processes, and uses thereof KRT18, CDC73, DSP CA12 1340/4885CA1 2905/4885MMP2 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.